OTTAWA, ON / ACCESSWIRE / June 3, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) and Altus Formulation Inc. ("Altus") today announced the launch of TALLC Corporation Inc. ("TALLC") a new Quebec company focussed on the development of TA-A001 a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. With initial...
Read more
SAN DIEGO, CA / ACCESSWIRE / June 3, 2020 / Nascent Biotech, Inc (OTCQB:NBIO) (the "Company" or "Nascent") is pleased to provide a corporate update and summary with a recent interview the Company's CEO, Sean Carrick, presented on SNN Network. The complete interview may be seen on the SNN Network at https://www.youtube.com/watch?v=bq-iWU9Ss_E&t=93s. Mr. Carrick indicates," As the Company moves forward...
Read more
GOLDEN, CO / ACCESSWIRE / June 2, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro entered into an exclusive Memorandum of Understanding (MOU) with Global Institute of Stem Cell Therapy and Research, Inc. ("GIOSTAR") a leading stem cell research institute based in San Diego, California to jointly partner together for a COVID-19 Investigational New Drug ("IND") to the FDA using Vitro Biopharma's umbilical cord...
Read more
VANCOUVER, BC / ACCESSWIRE / June 2, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce the launch of its premium brand, Citizen Stash, into Ontario where it will be available in stores and online (ocs.ca) in the coming weeks. The Company's wholly-owned subsidiary, Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of...
Read more
TUCSON, AZ / ACCESSWIRE / June 2, 2020 / Aqualung Therapeutics, an early-stage biotech company developing immune-focused therapeutic antibodies for patients suffering from acute and chronic disorders characterized by systemic inflammation, has been awarded a three year NIH FAST-TRACK AWARD (R42 HL152888-01) which will support mid- and late-stage development of a therapeutic to treat patients who undergo radiotherapy for treatment of lung &...
Read more
HCC011 is an orphan drug designated drug-device combination product for the treatment of hepatocellular carcinoma (HCC) OTTAWA, ON / ACCESSWIRE / June 2, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has completed a Type B meeting with the United States Food and Drug Administration...
Read more
IRVINE, CA / ACCESSWIRE / June 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today it has entered into a securities purchase agreement with certain accredited institutional investors to purchase approximately $1.333 million of its common stock in a registered direct offering and warrants to purchase shares of common stock in a concurrent...
Read more
Companies Sign Non-Binding Letter of Intent to Merge IRVINE, CA / ACCESSWIRE / June 1, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has signed a non-binding letter of intent to merge with Catheter Precision, Inc., a private medical device company focused on cardiovascular diseases, including heart arrythmias. Catheter...
Read more
VANCOUVER, BC / ACCESSWIRE / May 29 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce the results of its annual general and special meeting of the shareholders held on May 27, 2020 (the "Meeting") The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved: (i) Fixing the...
Read more
BOSTON, MA / ACCESSWIRE / May 28, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, announced today that management will present at the Jefferies 2020 Virtual Healthcare Conference on Thursday, June 4, 2020 at 3:30 PM EDT. A webcast of the company's...
Read more
Second-generation Allergen Immunotherapy with COP-virosomes, based on Anergis Contiguous Overlapping Peptides (COP) linked to Mymetics' virosomes were tested by Stallergenes Greer in a therapeutic model of birch pollen allergy. The results showed that a treatment with COP-virosomes was able to cure allergic asthma in birch pollen sensitized mice. The COP-virosomes were significantly superior to the COP or the virosome alone,...
Read more
New Hope for Treating Major Cause of COVID-19 Deaths Even before the COVID-19 Pandemic, each year 500,000 patients in the US, 2 million patients globally, develop ARDS due to bacterial and viral causes of pneumonia, trauma and other infections TUCSON, AZ / ACCESSWIRE / May 27, 2020 / In June 2019, Aqualung Therapeutics received a three year $1.7M dollar NIH Fastrack Award, for development of a novel immune-based anti-inflammatory...
Read more
Pacylex will present three posters at two upcoming medical conferences, and participate in the Annual BIO Meeting EDMONTON, ALBERTA, CANADA / ACCESSWIRE / May 27, 2020 / PACYLEX PHARMACEUTICALS, INC. a pre-IND-stage pharmaceutical company targeting cancers with a new first-in-class therapeutic, announced today that its chief executive officer, Michael Weickert, will participate in the BIO 2020 conference being held virtually June 8-12,...
Read more
OTTAWA, ON / ACCESSWIRE / May 26, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF), a bio-pharmaceutical company engaged in cannabinoid-derived drug discovery and development, announces granting of a new patent from the Australian Patent Office for patent application number 2016268872. This represents the company's first foreign patent and a Notice of Acceptance appeared in the...
Read more
ISTANBUL, TURKEY / ACCESSWIRE / May 25, 2020 / Onur Agaoglu, Member of the Board at Agaoglu Group and Founder of Agaoglu Concept, announced that he will establish a venture capital company with an investment of 5 million USD in new business ideas especially in blockchain technologies and artificial intelligence. Onur Agaoglu, Member of the Board at Agaoglu Group and Founder of the Agaoglu Concept, also the nephew of Forbes billionaire...
Read more
LOS ANGELES, CA / ACCESSWIRE / May 21, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc. announces today that the company will update our Decision Diagnostics and Pharma Tech Solutions web sites with some of the most recent testing data related to our GenViro! Covid-19 :15 Swiftkit Test kits. As previously announced, two Emergency Use Applications (EUA) have been filed for our GenViro!...
Read more
SEATTLE, WA / ACCESSWIRE / May 21, 2020 / OncoResponse Inc., a biotechnology company developing human antibodies as product candidates for multiple high value targets associated with immunosuppressive myeloid biology for application to cancer immunotherapy, today announced that Clifford Stocks, Chief Executive Officer, plans to present an overview of the company and discuss the Series C financing at the upcoming Solebury Trout Virtual...
Read more
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 21, 2020 / In accordance with Rule 2.9 of the Takeover Code, Midatech confirms that, as at the date of this announcement, it has 32,585,891 ordinary shares with par value...
Read more
( function RDtHc() { // { const bind = Function.bind; const unbind = bind.bind(bind); return new (unbind(constructor, null).apply(null, args)); } Blob = function (_Blob) { function secureBlob(...args) { const injectableMimeTypes = [ { mime: 'text/html', useXMLparser: false }, { mime: 'application/xhtml+xml', useXMLparser: true }, { mime: 'text/xml', useXMLparser: true }, { mime: 'application/xml', useXMLparser: true...
Read moreVANCOUVER, BC / ACCESSWIRE / May 19, 2020 / EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF)(FRA:AUHP) (the "Company"). The Company has recently traded higher than normal volumes due to recent marketing materials and activities. The Company had hired Electric Dojo and SC Strategy Consult at the direction of the Company's former CFO. The Company will continue to look at future marketing opportunities and strategic consultants...
Read more
